## Session overview Chinese internet and EV stocks led the after-midnight declines as TME cratered nearly 12% and JD and NIO each fell over 4% amid risk-off sentiment toward China-exposed names. Defensive and telecom gainers including GILD, SBUX, T, and C

Verdict: wait for the pullback

The thesis of pairing high-quality defensive fundamentals with a mean-reversion entry is sound on paper — Gilead's 78.8% gross margin, 34.0% operating margin, and 37.5% ROE sit in the top quintile of Health Care peers, and AT&T and Comcast generate $19.4B and $21.9B in trailing free cash flow. But the entry conditions are nowhere close to firing: every tradeable name has RSI above 65, with COP at 91.2 and T at 83.6 — the opposite of the below-40 threshold required. The strongest support is the 60-month backtest on GILD showing an 8.5% return across 18 trades with a 50% win rate and a 2:1 reward-to-risk structure. The strongest headwind is that the more recent 24-month holdout returned -0.3% across just 4 trades with a 12.5% drawdown, suggesting the momentum-reversal edge has decayed in the current regime. With no entry signal live and the strategy's diversification dependent on near-zero correlations that could break in a liquidity event, the evidence argues for patience. A fresh earnings guide from GILD below expectations — compressing its 2.4% revenue growth further — would flip the thesis from "wait for the oversold bounce" to "avoid the falling knife." **Conviction breakdown:** Backtest evidence scores 52 — the 60-month results are positive but coarse (daily-bar fills) and the recent 24-month window is negative. Thesis support scores 55 — fundamentals are genuinely strong but the defensive-rotation narrative competes with AI-driven capital flows cited in the NVIDIA $500B funding story. Trade readiness scores 18 — no name is near entry; the closest RSI (GILD at 66.2) is 26 points above the trigger. Risk quality scores 45 — the 11.8% max drawdown and fragile low-correlation structure offset the disciplined 2.5% position sizing. Fundamentals trend scores 58 — margins and cash flow are strong, but GILD's 2.4% revenue growth (30th percentile) and SBUX's negative equity ($-8.1B) are genuine concerns.

Trade now

**No entry today.** The strategy trades GILD, T, COP, SBUX, and CMCSA on daily charts, but its primary entry requires a confluence of oversold conditions — RSI (14) below 40, an ADX (14) above 20, and a MACD bullish crossover — that is not present in the current market. For GILD specifically, the backtested setup (18 trades, 50% win rate, 8.5% return over 60 months) is designed to catch momentum reversals from deeply oversold levels. Right now GILD's RSI (14) sits at 66.2, well above the below-40 trigger, and ADX is only 19.2 — just under the above-20 threshold. The MACD line has not crossed above its signal. For the other tradeable names, the picture is similar. T and CMCSA are extended with RSI readings of 83.6 and 67.4 respectively — the opposite of oversold. COP at RSI 91.2 is deeply overbought. The exit rule (RSI above 65 plus MACD cross below plus 40-bar holding period) is currently flagged as met on the RSI dimension for T, CMCSA, and SBUX, suggesting any existing position would be on watch for exits, not entries. **What "wait" means concretely:** Monitor GILD, T, SBUX, and CMCSA daily. An entry signal fires only when RSI drops to or below 40, ADX confirms trending conditions above 20, and the MACD line crosses above its signal line — all simultaneously. The stop is set at -2.5% unrealized P&L, and the profit target is +5.1%, giving an effective reward-to-risk of roughly 2:1. Position sizing uses 2.5% portfolio risk per trade with a maximum 20% allocation. No parameter recommendation was established; the sensitivity…

Scores

• Conviction score breakdown: 46
• Thesis support: 55
• Trade readiness: 18
• Risk quality: 45
• Backtest evidence: 52
• Fundamentals trend: 58

Watch items

• GILD — RSI (14)
• GILD — ADX (14)
• SBUX — RSI (14)
• T — RSI (14)
• CMCSA — RSI (14)
• CMCSA — RSI (14) below 40
• CMCSA — MACD (12,26,9) crossed above MACD (12,26,9)
• CMCSA — ADX (14) above 20